Corrigendum to "Neurobehavioral and genotoxic aspects of rosmarinic acid" [Pharmacol. Res. 52 (3) (2005) 199-203] (DOI:10.1016/j.phrs.2005.03.003);Neurobehavioral and genotoxic aspects of rosmarinic acid

Pharmacological Research

Volumn 52, Issue 3, 2005, Pages 199-203

  Pereira, Patrícia ^a   Tysca, Denise ^a   Oliveira, Paulo ^a   Brum, Lucimar Filot Da Silva ^a   Picada, Jaqueline Nascimento ^a   Ardenghi, Patrícia ^b,c  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b UNIVERSIDADE FEEVALE   (Brazil)

^c Fundacao Estadual de Producao e Pesquisa em Saude   (Brazil)

Author keywords

Anxiety; Comet assay; Locomotor activity; Memory; Rosmarinic acid

Indexed keywords

ROSMARINIC ACID;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN TISSUE; COGNITION; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; GENOTOXICITY; LOCOMOTION; LONG TERM MEMORY; MALE; MAZE TEST; MOTIVATION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

EID: 22144480225     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.07.006     Document Type: Erratum

References (24)

1. M.R. Al-Sereiti, K.M. Abu-Amer, and P. Sen Pharmacology of Rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials Indian J Exp Biol 37 1999 124 130
2. 2+-dependent pathways of T-cell antigen receptor-mediated signaling by onhibiting the PLC-γ1 and Itk activity Blood 101 2003 3534 3542
3. M. Petersen, and MS.J. Simmonds Rosmarinic acid Phytochemistry 62 2003 121 125
4. W. Bors, C. Michel, K. Stetmaier, Y. Lu, and Ly. Foo Antioxidant mechanisms of polyphenolic caffeic acid oligomers, constituents of Salvia officinalis Biol Res 37 2004 301 311
5. A. Sahu, N. Rawal, and M.K. Pangburn Inhibition of complement by covalent attachment of rosmarinic acid to activated C3B Biochem Pharmacol 57 1999 1439 1446
6. M.A. Kelm, M.G. Nair, G.M. Strasburg, and D.L. Dewitt Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn Phytomedicine 7 2000 7 13
7. W. Zheng, and S.Y. Wang Antioxidant acitivity and phenolic compounds in selected herbs J Agric Food Chem 49 2001 5165 5170
8. L.P. Gao, H.L. Wei, H.S. Zhao, Xiao Sy, and R.L. Zheng Antiapoptotic and antioxidant effects of rosmarinic acid in astrocytes Pharmazie 60 2005 62 65
9. H. Takeda, M. Tsuji, J. Miyamoto, and T. Matsumiya Rosmarinic acid and caffeic acid reduce the defensive freezing behavior of mice exposed to conditioned fear stress Psychopharmacology 164 2002 233 235
10. H. Takeda, M. Tsuji, M. Inazu, T. Egashira, and T. Matsumiya Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice Eur J Pharmacol 449 2002 261 267
11. F.S. D'Amelio Botanicals, a phytocosmetic desk reference 1999 CRC Press London
12. J.N. Picada, D.G. Flores, C.G. Zettler, N.P. Marroni, R. Roesler, and JA.P. Henriques DNA damage in brain cells of mice treated with an oxidized form of apomorphine Mol Brain Res 114 2003 80 85
13. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open: closed arms entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Meth 14 1985 140 176
14. I. Izquierdo, J.A. Quilfeldt, M.S. Zanatta, J. Quevedo, E. Schaeffer, and P.K. Schitz Sequential role of hippocampus and amygdala entorhinal cortex and parietal cortex in formation and retrieal of memory for inhibitory avoidance in rats Eur J Neurosci 9 1997 786 793
15. P. Pereira, P. Ardenghi, T. Mello e Souza, J.H. Medina, and I. Izquierdo Training in the step-down inhibitory avoidance task time-dependently inceases cAMP-dependent protein kinase activity in the endocrinal cortex Behav Pharmacol 12 2001 1 4
16. J.N. Picada, N. Schröder, I. Izquierdo, Henriques JAP, and R. Roesler Differential neurobehavioral deficits induced by apomorphine and its oxidation product, 8-0x0-apomorphine-semiquinone, in rats Eur J Pharmacol 443 2002 105 111
17. R.R. Tice, E. Agurell, D. Anderson, B. Burlinson, A. Hartmann, and Y. Kobayashi Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing Environ Mol Mutagen 35 2000 206 221
18. S.B. Nadin, M.L. Vargas-Roig, and D.R. Ciocca A silver staining for single-cell gel assay J Histochem Cytochem 49 2001 1183 1186
19. J. Da Silva, de Freitas TRO, V. Heuser, J.R. Marinho, F. Bittencourt, and Cerski CTS Effects of chronic exposure to coal in wild rodents (Ctenomys torquatus) evaluated by multiple methods and tissues Mutat Res 470 2000 39 51
20. J.M. Boeira, J. da-Silva, B. Erdtmann, and JA.P. Henriques Genotoxic effects of the alkaloids harman and harmine assessed by comet assay and chromosome aberration test in mammalian cells in vitro Pharmacol Toxicol 89 2001 287 294
21. I. Izquierdo, M.E. Pereira, and J.H. Medina Benzodiazepine ligand influences on aquisition: suggestions of an endogenous modulatory mechanism mediated by benzodiazepine receptors Behav Neural Biol 54 1990 27 41
22. P. Ferris, E. Seward, and G.R. Dawson Interactions between LY354740, a group II metabotropic agonist and the GABA (A)-benzodiazepine receptor complex in the rat on elevated plus-maze J Psychopharmacol 15 2 2001 76 82
23. A. Palucha, E. Tatarczynska, P. Branski, B. Szewczyk, J.M. Wieronska, and K. Klak Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats Neuropharmacology 46 2004 151 159
24. A. Hartmann, E. Agurell, C. Beevers, S. Brendler-Schwaab, B. Burlinson, and P. Clay Recommendations for conducting the in vivo alkaline Comet assay Mutagenesis 18 2003 45 51